Previous close | 176.52 |
Open | 175.30 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 175.30 - 176.92 |
52-week range | 162.20 - 264.40 |
Volume | |
Avg. volume | 233 |
Market cap | 77.77B |
Beta (5Y monthly) | 0.56 |
PE ratio (TTM) | 23.10 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.97 (1.20%) |
Ex-dividend date | 25 Apr 2022 |
1y target est | N/A |
Nektar (NKTR) signs a collaboration deal with Pfizer and Merck KGaA to develop a combination of its NKTR-255 with the latter's Bavencio for treating urothelial carcinoma.